Atlas Trials

CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer

Clinical trial NCT04560270 · COMPLETED

Trial details

NCT number
NCT04560270
Sponsor
Poitiers University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors
Start date
2016-04-25
Primary completion
2019-06-28
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.